(S (NP-SBJ (NP Human/JJ immunodeficiency/NN viruses/NNS) (VP containing/VBG (NP heterologous/JJ enhancer\/promoters/NNS))) (VP-COOD (VP are/VBP (ADJP-PRD replication/NN competent/JJ)) and/CC (VP exhibit/VBP (NP different/JJ lymphocyte/NN tropisms/NNS))) ./.)
(S (NP-SBJ The/DT (NP (NP human/JJ immunodeficiency/NN virus/NN) (PRN -LRB-/-LRB- (NP HIV/NN) -RRB-/-RRB-)) type/NN 1/CD (NP (NP long/JJ terminal/JJ repeat/NN) (PRN -LRB-/-LRB- (NP LTR/NN) -RRB-/-RRB-))) (VP contains/VBZ (NP (NP binding/VBG sites/NNS) (PP for/IN (NP (NP-COOD (NP (NP nuclear/JJ factor/NN kappa/NN B/NN) (PRN -LRB-/-LRB- (NP NF-kappa/NN B/NN) -RRB-/-RRB-)) and/CC (NP the/DT (ADJP constitutively/RB expressed/VBN) transcription/NN factor/NN Sp1/NN)) ,/, (SBAR (WHNP-59 (NP both/DT) (WHPP of/IN (WHNP which/WDT))) (S (NP-SBJ-60 *T*-59/-NONE-) (VP are/VBP (VP (ADVP highly/RB) conserved/VBN (NP *-60/-NONE-) (PP in/IN (NP (NP-COOD (NP HIV/NN) and/CC (NP simian/JJ immunodeficiency/NN virus/NN)) isolates/NNS)))))))))) ./.)
(S (S (NP-SBJ */-NONE-) (VP-COOD (VP To/TO (VP delineate/VB (NP (NP the/DT effects/NNS) (PP of/IN (NP these/DT motifs/NNS)) (PP on/IN (NP (NP the/DT replicative/JJ capacity/NN) (PP of/IN (NP HIV/NN))))))) and/CC (VP to/TO (VP explore/VB (NP (NP the/DT possibility/NN) (PP of/IN (S (NP-SBJ */-NONE-) (VP extending/VBG (NP the/DT virus/NN host/NN range/NN))))))))) ,/, (NP-SBJ-61 known/VBN heterologous/JJ enhancer\/promoters/NNS) (VP were/VBD (VP inserted/VBN (NP *-61/-NONE-) (PP into/IN (NP the/DT HIV-1/NN LTR/NN)) (PP in/IN place/NN of/IN (NP the/DT (NP-COOD (NP NF-kappa/NN B/NN) and/CC (NP Sp1/NN)) binding/NN sites/NNS)))) ./.)
(S (NP-SBJ-62 (NP The/DT effects/NNS) (PP of/IN (NP these/DT substitutions/NNS)) (PP-COOD (PP on/IN (NP (NP viral/JJ replication/NN) (PP in/IN (NP transfected/VBN HeLa/NN cells/NNS)))) and/CC (PP on/IN (NP (NP HIV/NN infection/NN) (PP of/IN (NP-COOD (NP human/JJ peripheral/JJ blood/NN lymphocytes/NNS) or/CC (NP continuous/JJ T-leukemia/NN cell/NN lines/NNS))))))) (VP were/VBD (VP evaluated/VBN (NP *-62/-NONE-))) ./.)
(S (NP-SBJ-63 (NP HIVs/NN) (SBAR (WHPP-64 in/IN (WHNP which/WDT)) (S (NP-SBJ-COOD-65 (NP the/DT NF-/NN kappa/NN B\/Sp1/NN enhancer/NN) plus/CC (NP the/DT downstream/JJ TATA/NN element/NN)) (VP were/VBD (VP replaced/VBN (NP *-65/-NONE-) (PP with/IN (NP heterologous/JJ enhancer\/promoters/NNS)) (PP *T*-64/-NONE-)))))) (VP were/VBD (VP (ADVP also/RB) constructed/VBN (NP *-63/-NONE-))) ./.)
(S (NP-SBJ (NP Viruses/NNS) (VP containing/VBG (NP the/DT human/JJ cytomegalovirus/NN immediate-early/JJ enhancer/NN))) (VP-COOD (VP exhibited/VBD (NP (NP infectious/JJ kinetics/NNS) (ADJP similar/JJ (PP to/TO (NP (NP that/DT) (PP of/IN (NP wild-type/JJ HIV/NN)))))) (PP in/IN (NP-COOD (NP activated/VBN human/JJ peripheral/JJ blood/NN lymphocytes/NNS) and/CC (NP AA2/NN cells/NNS)))) but/CC (VP replicated/VBD (ADVP less/RBR efficiently/RB) (PP in/IN (NP (NP-COOD (NP H9/NN) and/CC (NP CEM/NN)) cells/NNS)))) ./.)
(S (NP-SBJ These/DT studies/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ-103 heterologous/JJ enhancer/NN elements/NNS) (VP are/VBP (ADJP-PRD capable/JJ (PP of/IN (S (NP-SBJ-104 *-103/-NONE-) (VP restoring/VBG (NP (NP Tat/NN responsiveness/NN) (PP to/TO (NP the/DT HIV/NN LTR/NN))) (PP-COOD (PP in/IN the/DT context/NN of/IN (S (NP-SBJ *-104/-NONE-) (VP directing/VBG (NP reporter/NN gene/NN expression/NN)))) (CONJP as/RB well/RB as/IN) (PP in/IN (NP (NP the/DT production/NN) (PP of/IN (NP infectious/JJ progeny/NN virions/NNS))))))))))))) ./.)
